A toolkit developed to predict and analyze PROTAC-mediated ternary complexes using AlphaFold3 and Boltz-1.
-
Updated
Jul 17, 2025 - Python
A toolkit developed to predict and analyze PROTAC-mediated ternary complexes using AlphaFold3 and Boltz-1.
PROTAC-Splitter: a machine learning framework designed for automated annotation of PROTAC substructures.
Predicting PROTAC protein degradation activity via machine learning.
Empirical evaluation of which public-data features actually predict PROTAC E3-ligase tractability — and which merely track how well-studied a ligase is.
End-to-end computational framework for designing cancer identity reversion therapies: scRNA-seq → Waddington attractor mapping → epigenetic switch set prediction → TCIP bifunctional molecule design
Computational drug discovery and cheminformatics engine integrating SMILES graph perception, circular fingerprints, graph attention networks, ADME pharmacokinetic modeling, PROTAC ternary cooperativity, and multi-objective molecular optimization.
Computational cheminformatics, graph neural ADME prediction, covalent inhibitor target engagement, PROTAC ternary cooperativity, empirical docking, and de novo molecular optimization.
Computational drug discovery and cheminformatics engine combining SMILES graph perception, circular fingerprints, message-passing graph neural networks, multitask ADME pharmacokinetics, evolutionary de novo ligand optimization, empirical docking, and PROTAC ternary cooperativity modeling.
Computational cheminformatics, graph neural ADME modeling, empirical protein-ligand docking, PROTAC ternary cooperativity, and de novo molecular optimization platform.
Neosubstrate and Oligopeptide Binder Benchmarking for Ligase Engagement: scores peptide poses against targeted-protein-degradation machinery with Boltz-2 ternary co-folding, benchmarked against 285,996 observed small-molecule bridges.
Context-aware PROTAC degradation prediction with counterfactual pretraining on unlabeled molecule–target–E3 ligase records. NeurIPS 2026.
Arvinas — independent third-party profile of a public API surface, by API Evangelist. Arvinas is a clinical-stage biopharmaceutical company (NASDAQ: ARVN) headquartered in New Haven, Connecticut, developing targeted protein degradation therapeutics using its proprietary PROTAC (proteolysis targeting chimera) Discovery Engine.
To associate your repository with the protac topic, visit your repo's landing page and select "manage topics."